Blockchain Registration Transaction Record
CNS Pharmaceuticals (NASDAQ: CNSP) Raises $5 Million in Public Offering
CNS Pharmaceuticals (NASDAQ: CNSP) raises $5 million through a public offering with a healthcare-focused investor. Proceeds will support the development of anti-cancer drugs, including Berubicin for brain and CNS cancers. A.G.P./Alliance Global Partners is the placement agent for the offering.

This news matters as it showcases CNS Pharmaceuticals' ability to secure funding for its pipeline of anti-cancer drug candidates, particularly Berubicin for brain and CNS cancers. The successful offering highlights investor confidence in the company's potential for developing innovative treatments in the oncology space.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0x1b63abe98d14594a1e6990bbb341b45dac785cdd422b869e9677e1c1ed1cb97c |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | fast4izp-c8a0475ae3b6209a96fe633c38e60501 |